Standout Papers

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma 2014 2026 2018 2022 2.6k
  1. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma (2014)
    Stephen M. Ansell, Alexander M. Lesokhin et al. New England Journal of Medicine

Immediate Impact

21 by Nobel laureates 18 from Science/Nature 99 standout
Sub-graph 1 of 16

Citing Papers

Breast tumor microenvironment structures are associated with genomic features and clinical outcome
2022 Standout
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
3 intermediate papers

Works of Deepika Cattry being referenced

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout

Author Peers

Author Last Decade Papers Cites
Deepika Cattry 890 2144 151 1224 4 2.6k
Heather H. Sun 1110 1550 194 754 19 2.5k
Emma C. Scott 898 2247 304 1254 27 3.2k
Margaretha G.M. Roemer 1154 1314 168 737 11 2.1k
Theresa Marafioti 1690 974 65 461 10 2.0k
DY Mason 1220 677 212 664 9 1.8k
S.M. MacDonald 629 782 372 951 9 3.2k
S. H. Swerdlow 1793 1215 928 568 3 3.3k
Z. Abdulaziz 755 872 393 1077 9 3.7k
Andrew J. Long 234 2801 174 2724 10 4.5k
Karamjit Gill 2372 1539 228 548 19 2.9k

All Works

Loading papers...

Rankless by CCL
2026